ArticleHeliyon2024
The efficiency of bio-char as bitumen modifier.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Improving the mechanical properties of bitumen is an important goal for road pavements design. For this reason, new compounds are now being sought for testing as bitumen modifiers. In this work, the authors studied the effect that two different chars have on two 50/70 bitumens with different chemical and physical characteristics. A complete morphological, surface and bulk characterization of the two additives was carried out. In addition, rheology, Nuclear Magnetic Resonance (NMR) relaxometry and atomic force microscopy were used to analyze the effect that the two additives exert on the properties of the bitumens. According to the results, the char sample with high porosity could be used as a modifier of mechanical properties, while no rejuvenation effects were observed for either of the two additives tested. In addition, the two additives do not give rise to segregation phenomena.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.